CureDuchenne has announced an investment and partnership with Baebies to expand newborn screening for Duchenne muscular dystrophy. Learn more about Duchenne muscular dystrophy and the new partnership in this article here.
Recent News
- Gauss Partners with State of California on New COVID-19 Antibody Study
- BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices
- Baebies Announces FDA Acknowledgement of Emergency Use Notification for FINDER 1.5 Instrument and FINDER SARS-CoV-2 Test – RT-PCR within 17 Minutes
- Pediatric testing platform is producing accolades for Durham startup Baebies
- With new cash, Durham biopharma startup Emergo targets a big enemy: Flu